Dianthus Therapeutics Inc（DNTH）价格预测DNTHDianthus Therapeutics Inc

Alphio's DNTH stock price prediction model matches the current Dianthus Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $75.50 (+1.30%). The 1-week path is $71.76 (-3.72%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Dianthus Therapeutics Inc is currently priced at $82.37, which is significantly below the average analyst price target of $139.80 (calculated from targets of $135, $156, $128, and $158). However, the stock shows a very low RSI of 9.857, indicating it is oversold, which could suggest a potential rebound. The company has a high forward P/E ratio of 0, indicating no expected earnings growth in the near term, and a significant risk is its current net income loss of -$50,215,000 for Q2 2026. Given these factors, while there is potential for upside based on analyst targets, the current financial performance and technical indicators suggest holding rather than buying.

Dianthus Therapeutics Inc (DNTH) last closed at $74.53, losing -0.31%. These facts feed the 1-day and 1-week DNTH price prediction above.